SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-001460
Filing Date
2021-02-23
Accepted
2021-02-23 16:01:56
Documents
14
Period of Report
2021-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20210223x8k.htm   iXBRL 8-K 44577
2 EX-99.1 xncr-20210223xex99d1.htm EX-99.1 257862
3 GRAPHIC xncr-20210223xex99d1001.jpg GRAPHIC 5434
  Complete submission text file 0001558370-21-001460.txt   444708

Data Files

Seq Description Document Type Size
4 EX-101.SCH xncr-20210223.xsd EX-101.SCH 2975
5 EX-101.LAB xncr-20210223_lab.xml EX-101.LAB 15410
6 EX-101.PRE xncr-20210223_pre.xml EX-101.PRE 9959
7 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20210223x8k_htm.xml XML 4668
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 21665319
SIC: 2834 Pharmaceutical Preparations